⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
EXEL News
Exelixis Inc
EXEL SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Exelixis
prnewswire.com
EXEL
Levi & Korsinsky Announces Investigation of Securities Claims Against Exelixis, Inc. (EXEL)
accessnewswire.com
EXEL
Exelixis, Inc. (EXEL) Securities Fraud Investigation - Levi & Korsinsky
accessnewswire.com
EXEL
Exelixis Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Exelixis (EXEL)
prnewswire.com
EXEL
Exelixis, Inc. (EXEL) Securities Fraud Investigation - Levi & Korsinsky
accessnewswire.com
EXEL
Exelixis, Inc. (EXEL) Securities Fraud Investigation - Levi & Korsinsky
accessnewswire.com
EXEL
Form 8-K
sec.gov
EXEL
Handa Oncology Receives FDA Tentative Approval for OMCAZIO (cabozantinib) Capsules
accessnewswire.com
EXEL
Kuehn Law Encourages Investors of EXELIXIS, Inc. to Contact Law Firm
globenewswire.com
EXEL
Correction: Head and Neck Squamous Cell Carcinoma Market is Projected to Boost at a CAGR of 10.5% During the Forecast Period (2026–2036) Due to the Launch of Emerging Novel Immunotherapies | DelveInsight
globenewswire.com
JNJ
BNTX
GMAB
IMUX
INO
PDSB
AZN
GSK
MRK
BIIB
EXEL
REGN
CUE
IOBT
RAPT
PRE